156 related articles for article (PubMed ID: 20128969)
21. Blood ammonia level in liver cirrhosis: a conditio sine qua non to confirm hepatic encephalopathy?
Gundling F; Seidl H; Schmidt T; Schepp W
Eur J Gastroenterol Hepatol; 2008 Mar; 20(3):246-7. PubMed ID: 18301310
[No Abstract] [Full Text] [Related]
22. Terlipressin therapy for renal failure in cirrhosis.
Triantos CK; Samonakis D; Thalheimer U; Cholongitas E; Senzolo M; Marelli L; Leandro G; Patch D; Burroughs AK
Eur J Gastroenterol Hepatol; 2010 Apr; 22(4):481-6. PubMed ID: 19952764
[TBL] [Abstract][Full Text] [Related]
23. The role of protein metabolism in 204 liver cirrhotics with and without hepatic encephalopathy. I. Clinical and general biochemical findings.
Müting D; Kalk JF; Koussouris P; Motschenbacher MT; Rausche A
Hepatogastroenterology; 1986 Apr; 33(2):61-5. PubMed ID: 3721388
[TBL] [Abstract][Full Text] [Related]
24. Long-term rifaximin therapy as a primary prevention of hepatorenal syndrome.
Ibrahim ES; Alsebaey A; Zaghla H; Moawad Abdelmageed S; Gameel K; Abdelsameea E
Eur J Gastroenterol Hepatol; 2017 Nov; 29(11):1247-1250. PubMed ID: 28902040
[TBL] [Abstract][Full Text] [Related]
25. [Several factors in the pathogenesis of hepatic failure in patients with liver cirrhosis and bleeding from esophageal and gastric varicose veins].
Bour AV; Manuk'ian GV; Umruzakov IU; Shertsinger AG
Anesteziol Reanimatol; 1993; (2):32-4. PubMed ID: 7943876
[TBL] [Abstract][Full Text] [Related]
26. [On enzymatic blood ammonia determination in liver patients with and without hepatic coma].
Müting D; Buhl H; Eschrich W; Reikowski H
Med Welt; 1966 Oct; 43():2288-93. PubMed ID: 5977110
[No Abstract] [Full Text] [Related]
27. The hemodynamics of cirrhosis and the development of hepatorenal syndrome.
Perkins J
Liver Transpl; 2006 Jan; 12(1):162. PubMed ID: 16498712
[No Abstract] [Full Text] [Related]
28. Diagnostic significance of nitrates and nitrites and L-arginine, in development of hepatorenal syndrome in patients with end stage alcoholic liver cirrhosis.
Nickovic V; Kocic G; Bjelakovic G; Pavlovic R; Stojanovic I; Katanic R; Stojanovic S; Djindjic B
Ren Fail; 2013; 35(5):633-9. PubMed ID: 23651488
[TBL] [Abstract][Full Text] [Related]
29. Prognostic markers in patients with ascites and hepatorenal syndrome.
Nazal L; Cárdenas A
Dis Markers; 2011; 31(3):139-46. PubMed ID: 22045399
[No Abstract] [Full Text] [Related]
30. Helicobacter pylori infection, plasma ammonia levels, and psychometric testing in cirrhotic patients.
Zullo A; Rinaldi V; Meddi P; Hassan C; Winn S; Attili AF
Am J Gastroenterol; 1999 Aug; 94(8):2214-8. PubMed ID: 10445552
[TBL] [Abstract][Full Text] [Related]
31. Transplantation of cadaveric kidneys from patients with hepatorenal syndrome. Evidence for the functionalnature of renal failure in advanced liver disease.
Koppel MH; Coburn JW; Mims MM; Goldstein H; Boyle JD; Rubini ME
N Engl J Med; 1969 Jun; 280(25):1367-71. PubMed ID: 4890476
[No Abstract] [Full Text] [Related]
32. IL-6 and IL-18 in blood may discriminate cirrhotic patients with and without minimal hepatic encephalopathy.
Montoliu C; Piedrafita B; Serra MA; del Olmo JA; Urios A; Rodrigo JM; Felipo V
J Clin Gastroenterol; 2009 Mar; 43(3):272-9. PubMed ID: 18562979
[TBL] [Abstract][Full Text] [Related]
33. Hypokalemia-induced hepatic coma in cirrhosis. Occurrence despite neomycin therapy.
Artz SA; Paes IC; Faloon WW
Gastroenterology; 1966 Dec; 51(6):1046-53. PubMed ID: 5958605
[No Abstract] [Full Text] [Related]
34. Helicobacter pylori, hyperammonemia, and hepatic encephalopathy: is there a correlation?
Rinaldi V; Zullo A; Diana F; Capocaccia L
Am J Gastroenterol; 1997 Apr; 92(4):723-4. PubMed ID: 9128348
[No Abstract] [Full Text] [Related]
35. Molecular adsorbent recirculating system is ineffective in the management of type 1 hepatorenal syndrome in patients with cirrhosis with ascites who have failed vasoconstrictor treatment.
Wong F; Raina N; Richardson R
Gut; 2010 Mar; 59(3):381-6. PubMed ID: 19710033
[TBL] [Abstract][Full Text] [Related]
36. [The treatment of hepatic encephalopathy with Hepa-Mertz].
Podymova SD; Bueverov AO; Nadinskaia MIu
Ter Arkh; 1995; 67(6):45-7. PubMed ID: 7667779
[TBL] [Abstract][Full Text] [Related]
37. Prevention of hepatorenal syndrome in patients with cirrhosis and ascites: a pilot randomized control trial between pentoxifylline and placebo.
Tyagi P; Sharma P; Sharma BC; Puri AS; Kumar A; Sarin SK
Eur J Gastroenterol Hepatol; 2011 Mar; 23(3):210-7. PubMed ID: 21285885
[TBL] [Abstract][Full Text] [Related]
38. Acute cerebral edema as part of the syndrome of hepatic encephalopathy in an individual with chronic liver disease: a case report.
Jabbour N; Karavias D; Van Thiel DH
J Okla State Med Assoc; 1994 Nov; 87(11):501-3. PubMed ID: 7815183
[TBL] [Abstract][Full Text] [Related]
39. Terlipressin therapy for reversal of type 1 hepatorenal syndrome: a meta-analysis of randomized controlled trials.
Sagi SV; Mittal S; Kasturi KS; Sood GK
J Gastroenterol Hepatol; 2010 May; 25(5):880-5. PubMed ID: 20074149
[TBL] [Abstract][Full Text] [Related]
40. Terlipressin and albumin vs albumin in patients with cirrhosis and hepatorenal syndrome: a randomized study.
Martín-Llahí M; Pépin MN; Guevara M; Díaz F; Torre A; Monescillo A; Soriano G; Terra C; Fábrega E; Arroyo V; Rodés J; Ginès P;
Gastroenterology; 2008 May; 134(5):1352-9. PubMed ID: 18471512
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
